store at low temperature
store at -20°C
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 230.00 | |
5 mg | In stock | $ 578.00 | |
10 mg | In stock | $ 913.00 |
Description | Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV). |
Synonyms | Synagis, MEDI 493 |
Molecular Weight | N/A |
CAS No. | 188039-54-5 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Palivizumab 188039-54-5 Microbiology/Virology RSV Synagis MEDI 493 inhibitor inhibit